(Q54384034)

English

Anti-stromal therapy with imatinib inhibits growth and metastasis of gastric carcinoma in an orthotopic nude mouse model.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21387285

Anti-stromal therapy with imatinib inhibits growth and metastasis of gastric carcinoma in an orthotopic nude mouse model. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21387285

1 reference

based on heuristic

inferred from title

Kazuaki Chayama

10

object named as

Kazuaki Chayama

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21387285

8

object named as

Shinji Tanaka

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21387285

Yasuhiko Kitadai

2

object named as

Yasuhiko Kitadai

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21387285

9

object named as

Wataru Yasui

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21387285

5

object named as

Michiyo Kodama

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21387285

3

object named as

Kei Shinagawa

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21387285

6

object named as

Mayu Ohnishi

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21387285

Tomonori Sumida

1

object named as

Tomonori Sumida

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21387285

author name string

Miwako Tanaka

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21387285

Eiji Ohara

7

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21387285

language of work or name

0 references

publication date

1 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21387285

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21387285

128

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21387285

9

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21387285

2050-2062

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21387285

Cancer-related inflammation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

The tumor microenvironment and its role in promoting tumor growth

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Friends or foes - bipolar effects of the tumour stroma in cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Cancer-stromal cell interaction and tumor angiogenesis in gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Malignant epithelial cells in primary human lung carcinomas coexpress in vivo platelet-derived growth factor (PDGF) and PDGF receptor mRNAs and their protein products

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Platelet-Derived Growth Factor is AngiogenicIn Vivo

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Increasing tumor uptake of anticancer drugs with imatinib.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Role of KIT and platelet-derived growth factor receptors as oncoproteins

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Targeting the expression of platelet-derived growth factor receptor by reactive stroma inhibits growth and metastasis of human colon carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

A general review of the role of irinotecan (CPT11) in the treatment of gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Targeting the platelet-derived growth factor receptor in antivascular therapy for human ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Simultaneous inhibition of EGFR, VEGFR, and platelet-derived growth factor receptor signaling combined with gemcitabine produces therapy of human pancreatic carcinoma and prolongs survival in an orthotopic nude mouse model.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Modulation of tumor cell response to chemotherapy by the organ environment

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Expression of activated platelet-derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Basement membranes: structure, assembly and role in tumour angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Characterization of human renal fibroblasts in health and disease: II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Myofibroblasts and mechano-regulation of connective tissue remodelling

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Cancer-associated stromal fibroblasts promote pancreatic tumor progression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Expression of platelet-derived growth factor (PDGF)-B and PDGF-receptor β is associated with lymphatic metastasis in human gastric carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25812

21 January 2018

Identifiers

10.1002/IJC.25812

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21387285

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21387285

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54384034&oldid=2032994795"